Scholarly Index
Candida Cristina Quarta
Alexion Pharmaceuticals (United States); 10,224 total citations; 96 total publications; best world rank #215
Alexion Pharmaceuticals (United States)
10,224Total citations
96Total publications
37H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 247 | US 117 | 96.92 |
| Parathyroid Disorders and Treatments | Lifetime | 570 | US 233 | 96.69 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | 2021-2025 | 215 | US 79 | 92.12 |
| Parathyroid Disorders and Treatments | 2021-2025 | 911 | US 233 | 78.91 |